The Risks of Unsupervised Medication Distribution

This chapter explores the challenges and regulatory changes regarding medication for abortion, particularly the FDA's removal of certain restrictions. Through a troubling case of improper medication access leading to serious complications, it examines the safety and oversight concerns surrounding high-risk drugs.